Archives
-
Novobiocin: From Target Validation to Assay Design
2026-10-01
Novobiocin is an aminocoumarin antibiotic with applications extending from bacterial DNA gyrase studies to parasite selectivity testing. This article develops an evidence-centered framework for choosing orthogonal assays, interpreting concentration data, and separating promising target biology from translational readiness.
-
LRPPRC–Dasatinib Synergy in Tumor OXPHOS
2026-09-30
A 2026 study identified dasatinib as a synergistic partner for LRPPRC inhibition in OXPHOS-dependent cancer models. Its central mechanistic finding is that the two interventions disrupt complementary OXPHOS gene pools: dasatinib suppresses nuclear-encoded programs, whereas LRPPRC inhibition preferentially impairs mitochondrial genome-encoded transcripts.
-
Safer pDNA Delivery with Anti-Inflammatory Lipids
2026-09-30
The reference study shows that plasmid DNA lipid nanoparticles can trigger severe acute inflammation through the cGAS–STING pathway, limiting their use despite DNA’s potential for durable, promoter-controlled expression. Loading nitro-oleic acid into the particles reduced inflammatory toxicity and enabled substantially longer transgene expression, while formulation screening further improved expression in vitro.
-
2X Taq PCR Master Mix for Stress-Gene Validation
2026-09-29
Learn how 2X Taq PCR Master Mix supports defensible genotyping, TA cloning, and endpoint validation in plant stress research. This article translates cassava A20/AN1 findings into practical assay and workflow decisions.
-
Arachidonic Acid: Designing Better Lipid Assays
2026-09-29
Arachidonic Acid is more than an inflammatory stimulus: it is a time-dependent, compartment-sensitive substrate for lipid signaling. This guide translates recent humoral-immunity findings into practical decisions for eicosanoid, enzyme-inhibition, and immune-cell assay design.
-
6-OHDA Models: From Lesion to Translation
2026-09-28
6-OHDA hydrochloride remains a powerful tool for creating mechanistically interpretable catecholaminergic lesion models. This thought-leadership guide explains how to strengthen experimental validation, position the model against competing paradigms, and translate lesion biology into more reliable therapeutic and delivery decisions.
-
Worenine Modulates PBK/SRC Signaling in Lung Fibrosis
2026-09-28
The study combines network pharmacology, molecular docking, and cell and animal experiments to investigate how worenine may reduce pulmonary fibrosis. Its findings connect PBK/SRC-associated signaling with changes in TGF-β1/Smad, ERK, and NF-κB pathways, while providing preclinical evidence—not proof of clinical efficacy—for further study.
-
Ginsenoside Rg1 for Neuroimmune Research
2026-09-27
Build a reproducible neuroimmune workflow around Ginsenoside Rg1, from compound handling to behavioral, cytokine, synaptic, and gut-barrier readouts. A 2025 mouse study provides a defined prolonged-isoflurane model and points to regulatory T cells as a testable mechanism—not a clinical treatment claim.
-
Anisomycin Workflows for JNK-Linked Apoptosis
2026-09-25
Use Anisomycin to test JNK-linked stress signaling and apoptosis with a workflow that separates rapid pathway readouts from later cell-death outcomes. A 2025 social-memory study offers a useful contrast: it shows why pathway-specific controls matter, but does not establish Anisomycin as a memory mechanism.
-
Arachidonic Acid Workflows for Immune Research
2026-09-25
Use Arachidonic Acid to probe how lipid substrate availability shapes eicosanoid output and immune-cell responses. This workflow pairs pathway readouts with B-cell measurements, while separating practical assay recommendations from findings reported in a recent vaccination study.
-
Hypoxia Duration Drives Urothelial Inflammation In Vitro
2026-09-24
A 2024 in vitro study found that short enzyme-induced hypoxia stabilized HIF-1α and increased nitric oxide activity in rat urothelial cells, while longer exposure was needed to increase caspase-1 activity. Antioxidant and verapamil interventions support a duration-dependent ROS/TXNIP/NLRP3 interpretation, while leaving important questions about pathway specificity and translation to bladder outlet obstruction.
-
HCAR3 Structures Reveal Agonist Recognition and Selectivity
2026-09-24
Cryo-EM structures of agonist-bound HCAR3 and HCAR2, paired with cAMP assays, identify pocket features associated with ligand recognition and receptor preference. The findings provide a structural basis for studying HCAR3-selective signaling, while showing why Acifran should not be treated as an HCAR3-selective ligand on the evidence presented.
-
Filipin III for Mapping Hepatic Cholesterol Homeostasis
2026-09-23
Filipin III can reveal where membrane-accessible cholesterol is distributed, but its signal is not a direct measure of total liver cholesterol. This article connects Filipin-based imaging to Caveolin-1 research in MASLD and explains how to design and interpret spatial assays without overreading them.
-
SIS3: Strategic Control of TGF-β/Smad3 Signaling
2026-09-23
A translational perspective on SIS3 as a selective Smad3 inhibitor, connecting fibrosis research and renal disease models with emerging evidence that canonical TGF-β/SMAD3 signaling can be epigenetically amplified in early-stage lung adenocarcinoma.
-
Cassava A20/AN1 Genes Under Abiotic Stress
2026-09-22
This study shows that cassava Metip4, Metip8, and Metip11 broadly promote tolerance to drought, salinity, temperature extremes, and manganese stress, while differing in responses to cadmium and copper. By combining genetic, cellular, physiological, and transcriptomic approaches, the work provides evidence for both functional convergence and gene-specific specialization within the cassava A20/AN1 family.